Frequently Asked Questions about Abbott Laboratories (ABT)

Name: Abbott Laboratories (ABT) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Abbott Laboratories (ABT) do?

Accepted Answer

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products...

Question 2

Is Abbott Laboratories (ABT) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of ABT reveals an Altman Z-Score of 4.97 and a Piotroski F-Score of 6/9. These metrics, combined with its 5-year revenue trend ($44.33B most recent), help investors decide if ABT fits their risk profile.

Question 3

What is the current P/E ratio for ABT?

Accepted Answer

As of the latest trading session, Abbott Laboratories (ABT) has a trailing P/E ratio of 27.75.

Question 4

Who is the CEO of Abbott Laboratories?

Accepted Answer

The current Chief Executive Officer of Abbott Laboratories is Robert Ford.

Question 5

What was ABT's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Abbott Laboratories reported annual revenues of $44.33B (2025), $41.95B (2024), $40.11B (2023), $43.65B (2022), $43.08B (2021) respectively.

Question 6

Does ABT pay a dividend?

Accepted Answer

Abbott Laboratories currently pays a dividend to its shareholders, with a trailing dividend yield of 2.32%.

Question 7

How much debt and cash flow does ABT have?

Accepted Answer

In its latest reporting period, Abbott Laboratories generated $7.39B in Free Cash Flow against a total debt load of $15.07B.

Question 8

What is the Price-to-Book (P/B) ratio of Abbott Laboratories?

Accepted Answer

The Price-to-Book (P/B) ratio for Abbott Laboratories (ABT) is currently 3.47.

Question 9

What is the Price-to-Sales (P/S) ratio of ABT?

Accepted Answer

Based on trailing twelve-month data, Abbott Laboratories (ABT) trades at a Price-to-Sales (P/S) ratio of 4.06.

Question 10

What is Abbott Laboratories's Return on Equity (ROE)?

Accepted Answer

Abbott Laboratories (ABT) has a Return on Equity (ROE) of 12.89%, representing its profitability relative to shareholder equity.

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	44.3B	24.6B	8B	6.5B	3.74
2024-12	42B	21.3B	6.8B	13.4B	7.67
2023-12	40.1B	20B	6.4B	5.7B	3.30
2022-12	43.7B	22.3B	8.4B	6.9B	3.94
2021-12	43.1B	23.2B	9.2B	7.1B	3.97

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	44.3B	24.6B	8B	6.5B	3.74
2024-12	42B	21.3B	6.8B	13.4B	7.67
2023-12	40.1B	20B	6.4B	5.7B	3.30
2022-12	43.7B	22.3B	8.4B	6.9B	3.94
2021-12	43.1B	23.2B	9.2B	7.1B	3.97